Literature DB >> 16719187

Adrenal insufficiency in the critically III trauma population.

T A Gannon1, R C Britt, L J Weireter, F J Cole, J N Collins, L D Britt.   

Abstract

Acute adrenal insufficiency has been demonstrated in a number of patients with shock. This study was designed to evaluate the rate of occult adrenal insufficiency in the critically ill trauma population and to determine the impact of hypoproteinemia on the use of random cortisol levels as a marker for adrenal insufficiency. Forty-four patients were prospectively enrolled on admission to the trauma intensive care unit, with three excluded, for a total n of 41. Random total serum cortisol and albumin levels were drawn on hospital Days 1, 4, 8, and 14. Occult adrenal insufficiency was defined as a cortisol less than 25 mcg/dL in the setting of an albumin greater than 2.5 g/dL. The prevalence of cortisol less than 25 mcg/dL ranged from 51 to 81 per cent during the study period, and peaked on Days 4 and 8. Albumin 2.5 g/dL or less ranged from 37 to 60 per cent, and this prevalence also peaked on Days 4 and 8. The patients with a low albumin had a high prevalence of low cortisol, ranging from 67 to 100 per cent. The prevalence of adrenal insufficiency, with low cortisol and normal albumin, ranged from 41 to 82 per cent during the study period. None of our patients with occult adrenal insufficiency were treated with steroids, which was a decision made by the treating physicians. Among the patients with occult adrenal insufficiency, survival was 100 per cent. Occult adrenal insufficiency is common in critically ill trauma patients, and is a dynamic entity that can be acquired and even resolved during critical illness. Random cortisol of 25 mcg/dL may actually not be an adequate marker of occult adrenal insufficiency. Low albumin predicts a low cortisol. Hemodynamically stable occult adrenal insufficiency should not be treated with steroid replacement in the critically ill trauma patient, as survival in our series was 100 per cent without replacement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16719187

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

1.  Physiologic responses to severe hemorrhagic shock and the genesis of cardiovascular collapse: can irreversibility be anticipated?

Authors:  Hernando Gómez; Jaume Mesquida; Linda Hermus; Patricio Polanco; Hyung Kook Kim; Sven Zenker; Andrés Torres; Rajaie Namas; Yoram Vodovotz; Gilles Clermont; Juan Carlos Puyana; Michael R Pinsky
Journal:  J Surg Res       Date:  2012-03-10       Impact factor: 2.192

2.  Prospective evaluation of admission cortisol in trauma.

Authors:  Amy M Kwok; James W Davis; Rachel C Dirks; Lawrence P Sue; Mary M Wolfe; Krista Kaups
Journal:  Trauma Surg Acute Care Open       Date:  2020-01-19

Review 3.  The hypothalamic-pituitary-adrenal axis in critical illness.

Authors:  Shekhar Venkataraman; Ricardo Munoz; Cristina Candido; Selma Feldman Witchel
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

4.  Acute Hypothalamic-pituitary-adrenal response in traumatic brain injury with and without extracerebral trauma.

Authors:  Juan A Llompart-Pou; Joan M Raurich; Jon Pérez-Bárcena; Antonia Barceló; Jordi Ibáñez; José I Ayestarán
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

5.  Metabolic changes after polytrauma: an imperative for early nutritional support.

Authors:  Erik Hasenboehler; Allison Williams; Iris Leinhase; Steven J Morgan; Wade R Smith; Ernest E Moore; Philip F Stahel
Journal:  World J Emerg Surg       Date:  2006-10-04       Impact factor: 5.469

Review 6.  Predicting cardiorespiratory instability.

Authors:  Michael R Pinsky; Gilles Clermont; Marilyn Hravnak
Journal:  Crit Care       Date:  2016-03-16       Impact factor: 9.097

7.  Are traumatic bilateral adrenal injuries associated with higher morbidity and mortality?-A prospective observational study.

Authors:  Ananya Panda; Atin Kumar; Shivanand Gamanagatti; Ashu Seith Bhalla; Raju Sharma; Subodh Kumar; Biplab Mishra
Journal:  J Trauma Manag Outcomes       Date:  2015-08-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.